Predictive value of transvaginal ultrasound blood flow parameters combined with serum anti-mullerian hormone for <i>in vitro</i> fertilization embryo transfer pregnancy failure in polycystic ovary syndrome infertility

ZHANG Jinling; LI Yongle

doi:10.7619/jcmp.20233003

Journal of Clinical Medicine in Practice > 2024 > 28(4): 125-130, 135. > DOI: 10.7619/jcmp.20233003

ZHANG Jinling, LI Yongle. Predictive value of transvaginal ultrasound blood flow parameters combined with serum anti-mullerian hormone for in vitro fertilization embryo transfer pregnancy failure in polycystic ovary syndrome infertility[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 125-130, 135. DOI: 10.7619/jcmp.20233003

Citation:

PDF (1230 KB)

Predictive value of transvaginal ultrasound blood flow parameters combined with serum anti-mullerian hormone for in vitro fertilization embryo transfer pregnancy failure in polycystic ovary syndrome infertility

ZHANG Jinling¹,
LI Yongle²

1.
Department of Ultrasound, Henan Reproductive and Obstetrics Hospital, Reproductive Health Research Institute of Henan Province, Zhengzhou, Henan, 450003
2.
Reproductive Medicine Center, Henan Reproductive and Obstetrics Hospital, Reproductive Health Research Institute of Henan Province, Zhengzhou, Henan, 450003

More Information

Received Date: September 19, 2023
Revised Date: January 14, 2024
Available Online: March 05, 2024

Graphical Abstract

Abstract

Abstract

Objective
To explore the predictive value of transvaginal ultrasound blood flow parameters combined with serum anti mullerian hormone (AMH) for in vitro fertilization embryo transfer (IVF-ET) pregnancy failure in infertility with polycystic ovary syndrome (PCOS).
Methods
A total of 173 infertile PCOS patients who underwent IVF-ET were selected as the study objects, of which 12 cases fell off. According to the results of vaginal Bultrasound on the 28th day after embryo transfer, 161 patients were divided into failed pregnancy group (n=96) and successful pregnancy group (n=65). The levels of resistance index (RI), pulsatile index (PI), ratio of maximum systolic to diastolic blood flow velocity (S/D), and serum AMH were compared between the two groups. Multivariate Logistic regression analysis was used to analyze the influencing factors of pregnancy failure in IVF-ET with PCOS infertility. Receiver operating characteristic (ROC) curves were drawn to analyze RI, PI, S/D and serum AMH levels alone and their combination to evaluate the predictive valueof IVF-ET pregnancy failure in PCOS infertility patients.
Results
The serum AMH level in the failed pregnancy group was significantly lower than that in the successful pregnancy group, and the blood flow RI, PI and S/D were higher than those in the successful pregnancy group (P < 0.001). RI (OR=4.688, 95%CI, 2.878 to 6.498), PI (OR=4.332, 95%CI, 2.277 to 6.387), S/D (OR=3.773, 95%CI, 1.856 to 5.691) and luteinizing hormone (LH)/follicle stimulating hormone (FSH) values on the third day of menstrual cycle (OR=2.998, 95%CI, 1.236 to 4.760) were the risk factors for pregnancy failure in PCOS infertility IVF-ET (P < 0.05); high FSH level on the third day of menstruation (OR=0.579, 95%CI, 0.416 to 0.806), high serum AMH level (OR=0.722, 95%CI, 0.533 to 0.911) and endometrial thickness on human chorionic gonadotropin (hCG)day (OR=0.632, 95%CI, 0.421 to 0.843) were protective factors for pregnancy failure in IVF-ET in PCOS infertility (P < 0.05). The sensitivity, specificity and area under the curve (AUC) of RI, PI and S/D combined with serum AMH levels in predicting pregnancy failure in IVF-ET of PCOS infertility were 95.83%, 80.00% and 0.933, respectively.
Conclusion
The combination of ultrasonic blood flow parameters and AMH has a good value in predicting pregnancy failure in IVF-ET of PCOS infertility.

FullText(HTML)

References (18)

References

[1]	SIDDIQUI S, MATEEN S, AHMAD R, et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)[J]. J Assist Reprod Genet, 2022, 39(11): 2439-2473. doi: 10.1007/s10815-022-02625-7
[2]	COLLÉE J, MAWET M, TEBACHE L, et al. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments[J]. Gynecol Endocrinol, 2021, 37(10): 869-874. doi: 10.1080/09513590.2021.1958310
[3]	FARLAND L V, STERN J E, LIU C L, et al. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts[J]. Hum Reprod, 2022, 37(11): 2690-2699. doi: 10.1093/humrep/deac210
[4]	SANTOS ROCA A J, MEJÍAS RAMOS J L, LYNCH L, et al. Prenatal diagnosis of Vasa previa by routine transvaginal color Doppler[J]. P R Health Sci J, 2021, 40(2): 90-92.
[5]	王英华, 鲁海鸥, 李芷舒, 等. 胚胎移植日经阴道三维超声评估子宫内膜容受性对体外受精/卵泡质内单精子显微注射-胚胎移植患者妊娠结局预测价值研究[J]. 临床军医杂志, 2020, 48(2): 191-192. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ202002023.htm
[6]	MOOLHUIJSEN L M E, VISSER J A. Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function[J]. J Clin Endocrinol Metab, 2020, 105(11): 3361-3373. doi: 10.1210/clinem/dgaa513
[7]	TEEDE H J, MISSO M L, COSTELLO M F, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J]. Hum Reprod, 2018, 33(9): 1602-1618. doi: 10.1093/humrep/dey256
[8]	栗凤霞, 王艳硕, 史艳想, 等. 维生素E联合二甲双胍治疗对多囊卵巢综合征不孕症患者的影响[J]. 实用临床医药杂志, 2022, 26(14): 97-100, 104. doi: 10.7619/jcmp.20220640
[9]	周晓燕, 汤美玲, 马娟, 等. 多囊卵巢综合征患者体外受精-胚胎移植妊娠结局的影响因素及预测[J]. 中国妇产科临床杂志, 2020, 21(4): 370-373. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202004009.htm
[10]	SHI L Y, HUANG L J, LIU L, et al. Diagnostic value of transvaginal three-dimensional ultrasound combined with color Doppler ultrasound for early cesarean scar pregnancy[J]. Ann Palliat Med, 2021, 10(10): 10486-10494. doi: 10.21037/apm-21-2208
[11]	张敏, 阮加里, Frempong, 等. 孕早期子宫动脉血流动力学参数对反复妊娠丢失患者妊娠结局的预测价值[J]. 中华生殖与避孕杂志, 2021, 41(7): 624-630.
[12]	陶沙, 吕莎, 曾贞. 经阴道超声检测参数对PCOS不孕症患者子宫内膜容受性的评估研究[J]. 中国性科学, 2020, 29(8): 75-78. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ202008025.htm
[13]	刘耘利, 许伟标, 刘琼珠, 等. 经阴道三维超声对体外受精-胚胎移植患者子宫内膜容受性的评估及对妊娠结局的预测价值[J]. 中国临床医学影像杂志, 2021, 32(6): 426-431. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX202106014.htm
[14]	BEDENK J, VRTAĈNIK-BOKAL E, VIRANT-KLUN I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility[J]. J Assist Reprod Genet, 2020, 37(1): 89-100.
[15]	BUTLER W J, PICO A, HAWKINS K C, et al. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment[J]. Gynecol Endocrinol, 2021, 37(9): 798-801. doi: 10.1080/09513590.2020.1862788
[16]	派尔旦木·那斯尔, 努尔比亚·阿布拉. 血清抗苗勒管激素及性激素水平对多囊卵巢综合征不孕患者促排卵治疗后排卵结局的影响[J]. 中国性科学, 2022, 31(8): 33-37. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ202208010.htm
[17]	曹阳阳, 常旺燕. 年龄、LH/FSH、AMH对体外受精-胚胎移植临床结局的预测价值[J]. 医学临床研究, 2022, 39(1): 63-66.
[18]	邓小艳, 刘莉, 李金丽, 等. Glycodelin-A与IVF-ET的子宫内膜容受性及妊娠结局的关系[J]. 中国妇产科临床杂志, 2021, 22(1): 33-35. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202101012.htm

Cited By

Get Citation

PDF

XML

Article views (109) PDF downloads (5)

Turn off MathJax

Article Contents

Abstract

References

Predictive value of transvaginal ultrasound blood flow parameters combined with serum anti-mullerian hormone for in vitro fertilization embryo transfer pregnancy failure in polycystic ovary syndrome infertility

Abstract

References

Catalog

Export File

Citation

Format

Content